Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema

Heterogeneous Emphysema Clinical Trial

Official title:
Comparative Study of Bronchoscopic Lung Volume Reduction to Evaluate Relative Efficacy in Patients With Non-Upper Lobe Emphysema

Status Completed

Clinical Trial Summary

Hypothesis: Patients with advanced emphysema with predominance of the disease in areas other than the upper lobes, as determined by high resolution computed tomography (HRCT), could have a positive response to valve treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00825578
Study type	Interventional
Source	Royal Brompton & Harefield NHS Foundation Trust
Contact
Status	Completed
Phase	Phase 3
Start date	January 2009
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00684892` - Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)	Phase 1/Phase 2
Recruiting	`NCT01902732` - Endoscopic Lung Volume Reduction After Catheter-based CV Measurement in Patients With Heterogeneous Emphysema and Complete Interlobar Fissures	Phase 2/Phase 3
Completed	`NCT02022683` - To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves	N/A